Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis KBL982, its oral obesity drug candidate.
KBL982 is a new drug candidate that the company is developing through the South Korean National New Drug Development Program.
The company secured KBL982 through its Smartiom platform for the development of microbiome therapeutics.
In animal studies, KBL982 was shown to reduce hepatic fat accumulation, protect the gut barrier, and restore gut microbiome imbalance.
KBL982-based obesity drugs are expected to offer specific benefits, including regulation of glucose metabolism, gut barrier protection, stimulation of glucagon-like peptide-1 (GLP-1) secretion, and restoration of gut microbiota imbalance caused by high-fat diets.
Kobiolabs aims to develop a fundamental obesity treatment that does not have the side effect of weight regain, which is often associated with GLP-1 receptor agonists.
Write to In-Hyuk Park at hyuk@hankyung.com
An LG Chem researcher LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech company, for up to $350 million, the two companies said on Thursday.Under the agreement, LG will receive $100 million up fro
South Korea’s Inventage Lab Inc. announced on Friday that it has signed a joint development agreement with Yuhan Corp. for a long-acting injectable for the treatment of obesity and diabetes.Inventage Lab is developing a pipeline of differentiated long-acting injectables using its propr
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company’s exclusive efpeglenatide, a glucagon-like peptide 1 (GLP-1) receptor agonist candidate for treating obesity and diabetes. Efpeglenati
Kobiolabs Co., South Korea's new drug development company for microbiomes, announced on Tuesday that it has signed a memorandum of understanding for comprehensive business cooperation with Kakao Healthcare.The agreement aims to explore personalized precision medical and nutrition solutions rel